3.
SCC组和ADC组的病理结果
Pathological results of patients in SCC and ADC groups
| Variables | SCC | ADC | P |
| Visceral pleural invasion | 18 (30%) | 38 (51.4%) | 0.013 |
| Lymphovascular invasion | 2 (3.3%) | 6 (8.1%) | 0.240 |
| Ki-67 index (%) | 55.42±21.80 | 35.20±27.05 | < 0.001 |
| pN stage | |||
| N0 | 35 (58.3%) | 45 (60.8%) | 0.896 |
| N1 | 19 (31.7%) | 24 (32.4%) | 0.925 |
| N2 | 11 (18.3%) | 23 (31.1%) | 0.093 |
| 4L metastasis | 5 (8.3%) | 17 (23%) | 0.023 |
| Station 5 metastasis | 6/42 (14.3%) | 11/55 (20%) | 0.402 |
| Station 6 metastasis | 1/13 (7.7%) | 3/16 (18.75%) | 0.421 |
| Station 7 metastasis | 5/60 (8.3%) | 6/74 (8.1%) | 0.962 |
| Station 8 metastasis | 1/7 (14.3%) | 0/11 (0) | 0.365 |
| Station 9 metastasis | 3/51 (5.9%) | 0/52 (0) | 0.116 |
| Station 10 metastasis | 16/60 (26.7%) | 18/74 (24.3%) | 0.758 |
| Station 11 metastasis | 6/43 (14%) | 9/50 (18%) | 0.694 |
| Station 12 metastasis | 1/2 (50%) | 1/7 (14.3%) | 0.881 |
| pTNM stage | |||
| Ⅰ | 22 (36.6%) | 37 (50%) | 0.123 |
| Ⅱ | 20 (33.3%) | 12 (16.2%) | 0.021 |
| Ⅲ | 17 (28.3%) | 25 (33.8%) | 0.500 |
| Ⅳ | 1 (1.7%) | 0 | 0.267 |